These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8405095)

  • 1. Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats.
    Huether G; Poeggeler B; Adler L; Rüther E
    Eur J Pharmacol; 1993 Jul; 238(2-3):249-54. PubMed ID: 8405095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the intracellular and extracellular serotonin in the regulation of melatonin production in rat pinealocytes.
    Miguez JM; Simonneaux V; Pevet P
    J Pineal Res; 1997 Sep; 23(2):63-71. PubMed ID: 9392444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice.
    Darmani NA
    Pharmacol Biochem Behav; 1998 May; 60(1):83-90. PubMed ID: 9610928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van de Kar LD
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat.
    Wilson AW; Neill JC; Costall B
    Alcohol; 1998 Oct; 16(3):249-70. PubMed ID: 9744857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract.
    Huether G; Poeggeler B; Reimer A; George A
    Life Sci; 1992; 51(12):945-53. PubMed ID: 1518369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
    Gundlah C; Martin KF; Heal DJ; Auerbach SB
    J Pharmacol Exp Ther; 1997 Nov; 283(2):581-91. PubMed ID: 9353373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats.
    Bauer CT; Banks ML; Blough BE; Negus SS
    Psychopharmacology (Berl); 2015 Sep; 232(17):3249-58. PubMed ID: 26041338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
    Jakus R; Graf M; Juhasz G; Gerber K; Levay G; Halasz P; Bagdy G
    Exp Neurol; 2003 Dec; 184(2):964-72. PubMed ID: 14769389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal plasma melatonin concentrations in healthy volunteers: effect of single doses of d-fenfluramine, paroxetine, and ipsapirone.
    Nathan PJ; Norman TR; Burrows GD
    J Pineal Res; 1996 Sep; 21(2):55-8. PubMed ID: 8912230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan Hydroxylase 2 Deficiency Modifies the Effects of Fluoxetine and Pargyline on the Behavior, 5-HT- and BDNF-Systems in the Brain of Zebrafish (
    Evsiukova VS; Bazovkina D; Bazhenova E; Kulikova EA; Kulikov AV
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan.
    Soblosky JS; DuMontier G; Jeng I
    J Neurochem; 1985 Dec; 45(6):1923-31. PubMed ID: 3932597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1998 Jul; 138(1):67-75. PubMed ID: 9694528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides.
    Jørgensen H; Kjaer A; Knigge U; Møller M; Warberg J
    J Neuroendocrinol; 2003 Jun; 15(6):564-71. PubMed ID: 12716407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
    Li Q; Murakami I; Stall S; Levy AD; Brownfield MS; Nichols DE; Van de Kar LD
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1261-7. PubMed ID: 8968349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.